
CLVR — Clever Leaves Holdings Inc
PINK · Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
+$0.00 (+0.00%)
Clever Leaves Holdings Inc (CLVR) is a drug manufacturers - specialty & generic company listed on PINK. It is led by Andres Fajardo, based in Bodega 19-B, Parque Ind. Tibitoc P.H, Tocancipá, Colombia, 251017, with about 296 employees. Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
Latest reported CLVR revenue for 2023-12-31 was $17.4M. Net income was -$17.9M. Revenue was up 355.9% from 2023-09-30 to 2023-12-31. CLVR currently screens at market cap $1.4K.
Use this CLVR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CLVR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CLVR SEC filings page. Lician reads the product cache first so this HTML stays unique to Clever Leaves Holdings Inc even when a live quote feed is slow.
About Clever Leaves Holdings Inc
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
CLVR Key Statistics
Market Cap
$0.00M
Previous Close
$0.00
Day Range
$0.00 – $0.00
EPS
-$11.42
Revenue
$17.42M
Net Income
-$17.90M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+6.1%
Profit Margin
-102.8%
Employees
296
CLVR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | $17.42M | $16.41M | $15.37M | $12.12M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$17.90M | -$66.17M | -$45.73M | -$36.67M |
| EPS (Diluted) | -$11.42 | -$51.70 | -$1.78 | -$3.34 |
Total Assets
$31.24M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$6.83M
Operating Cash Flow
-$11.51M
Free Cash Flow
$0.00
Clever Leaves Holdings Inc Company Information
- Co-Founder, CEO & Director
- Andres Fajardo
- Headquarters
- Bodega 19-B, Parque Ind. Tibitoc P.H, Tocancipá, Colombia, 251017
- Website
- cleverleaves.com
- Phone
- 561 634 7430
- IPO / Founded
- 2020-12-18
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic